Pulmonary arterial hypertension in HIV infection: a concise review

Heart Lung Circ. 2014 Apr;23(4):299-302. doi: 10.1016/j.hlc.2013.10.088. Epub 2013 Oct 31.

Abstract

Pulmonary arterial hypertension (PAH) is an infrequent but nevertheless serious life threatening severe complication of human immunodeficiency virus (HIV) infection. In today's era of antiretroviral therapy (ART), the mortality of HIV patients has greatly reduced due to improved immune function and fewer opportunistic infections. However, these patients have an increased incidence of PAH. In this review, we will mainly discuss HIV-related pulmonary arterial hypertension (HRPH) in terms of the epidemiology, pathogenesis, clinical characteristics and treatment.

Keywords: Aetiology; HIV; Hypertension; Pulmonary; Therapeutics.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • HIV Infections* / complications
  • HIV Infections* / epidemiology
  • HIV Infections* / pathology
  • HIV Infections* / physiopathology
  • HIV Infections* / therapy
  • HIV-1*
  • Humans
  • Hypertension, Pulmonary* / epidemiology
  • Hypertension, Pulmonary* / etiology
  • Hypertension, Pulmonary* / pathology
  • Hypertension, Pulmonary* / therapy